Reported positive initial data from INSPIRE DUCHENNE trial of next-generation Duchenne gene therapy candidate, SGT-003; In mid-2025, ...

(NYSE: VHI) reported net income attributable to Valhi stockholders of $22.8 million, or $.80 per share, in the fourth quarter ...

Gap has been in the midst of a turnaround under CEO Richard Dickson and has blown away Wall Street expectations for four ...

The banking sector, which recorded earnings growth of 7.9% year-on-year (y-o-y) in 2024, is expected to see earnings rise by ...

Gross profit margin for the fourth quarter of 2024 was 50.2% as compared to 48.8% in the third quarter of 2024. The quarter-over-quarter 140 basis-point expansion was driven by improvements in ...

Strong unlevered balance sheet with $70.1 million in cash and no debtRepurchased $8.1 million of common stock in 2024Increased refrigerant ...

Revenue Growth of 28%Expects 2025 Revenue of $126 Million to $130 Million Without Need for Additional Capital BELGRADE, MT / ACCESS Newswire / March 6, 2025 / Xtant Medical Holdings, Inc.

After years of being down in the dumps, Gap Inc. for the past four quarters has been on firmer footing and working to inject ...